Cost-effectiveness analysis of infliximab versus CinnoRA in the treatment of moderate to severe ulcerative colitis in Iranian patients

Olfatifar, M.; Asadzadeh Aghdaei, H.; Hasanpour Dehkordi, A.; Shahrokh, S.; Pourhoseingholi, M.A.; Balaii, H.; Mohsen Rajabnia, M.; Ivanchuk, Maria; Ivanchuk, Pavlo; Hashemi Nazari, S.; Sabour, S.; Rohani, P.; Mehralian, G.; Khodakarim, S.; Hatami, B.; Malekpour, H.; Sherkat, G.; Zali, M.R.; Rahimi Pordanjani, S.

dc.contributor.author	Olfatifar, M.
dc.contributor.author	Asadzadeh Aghdaei, H.
dc.contributor.author	Hasanpour Dehkordi, A.
dc.contributor.author	Shahrokh, S.
dc.contributor.author	Pourhoseingholi, M.A.
dc.contributor.author	Balaii, H.
dc.contributor.author	Mohsen Rajabnia, M.
dc.contributor.author	Ivanchuk, Maria
dc.contributor.author	Ivanchuk, Pavlo
dc.contributor.author	Hashemi Nazari, S.
dc.contributor.author	Sabour, S.
dc.contributor.author	Rohani, P.
dc.contributor.author	Mehralian, G.
dc.contributor.author	Khodakarim, S.
dc.contributor.author	Hatami, B.
dc.contributor.author	Malekpour, H.
dc.contributor.author	Sherkat, G.
dc.contributor.author	Zali, M.R.
dc.contributor.author	Rahimi Pordanjani, S.
dc.date.accessioned	2025-02-12T11:50:18Z
dc.date.available	2025-02-12T11:50:18Z
dc.date.issued	2023
dc.identifier.other	DOI:10.34172/ipp.2022.29293
dc.identifier.uri	http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/26160
dc.description.abstract	Objectives: This study was done to evaluate the cost-effectiveness of IFX versus CinnoRA for the treatment of moderate-to-severe UC patients. Conclusion: Our results demonstrated that IFX is more effective and more costly than CinnoRA, and if we ignore the predicted surgeries, CinnoRA is nearly as effective as IFX. However, these ﬁndings should be cautiously interpreted without a robust clinical trial of CinnoRA in UC patients. Since the impact of CinnoRA may have been over/underestimated.	uk_UA
dc.language.iso	en	uk_UA
dc.publisher	Immunopathologia Persa (міжнародний рецензований журнал)	uk_UA
dc.subject	Cost-effectiveness	uk_UA
dc.subject	inﬂiximab	uk_UA
dc.subject	CinnoRA	uk_UA
dc.subject	Ulcerative colitis	uk_UA
dc.subject	Microsimulation	uk_UA
dc.title	Cost-effectiveness analysis of infliximab versus CinnoRA in the treatment of moderate to severe ulcerative colitis in Iranian patients	uk_UA
dc.type	Article	uk_UA